In vitro radiosensitizing effects of temozolomide on U87MG cell lines of human glioblastoma multiforme
IJMS-Iranian Journal of Medical Sciences. 2017; 42 (3): 258-265
em Inglês
| IMEMR
| ID: emr-191150
ABSTRACT
Background:
Glioma is the most common primary brain tumor with poor prognosis. Temozolomide [TMZ] has been used with irradiation [IR] to treat gliomas. The aim of the present study was to evaluate the cytotoxic and radiosensitizing effect of TMZ when combined with high-dose and high-dose rate of gamma irradiation in vitro
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Iran. J. Med. Sci.
Ano de publicação:
2017
Similares
MEDLINE
...
LILACS
LIS